Kamada vs Organogenesis
KMDA and ORGO side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How KMDA and ORGO compare
Kamada grew revenue faster over the last twelve months (13.2% versus 6.5% for Organogenesis).
Organogenesis scores higher on the StockData Score (9 against 5 for Kamada), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | KMDA | ORGO |
|---|---|---|
| Size and price | ||
| Market cap | – | $103M |
| Share price | $8.11 | $0.803 |
| Change, 1 year | 14.5% | −87.1% |
| Change, 5 years | 28.5% | −91.9% |
| Beta (5Y) | 0.84 | 0.59 |
| Employees | 393 | 854 |
| StockData Score | ||
| Total score | 5 | 9 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 (better) | 0 |
| Performance score | 0 | 3 (better) |
| Health score | 3 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 0.2× |
| P/B | – | 0.7× |
| P/FCF | – | 5.0× |
| FCF yield | – | 20.2% |
| Growth | ||
| Revenue growth (TTM) | 13.2% (better) | 6.5% |
| Revenue growth, 5Y average | 6.3% | 10.8% (better) |
| EPS growth, 5Y average | −1.6% | 0.00% (better) |
| Profitability | ||
| Gross margin | 40.8% | – |
| Operating margin | 14.5% (better) | −7.8% |
| Net margin | – | −18.4% |
| FCF margin | – | 4.6% |
| Return on equity | – | −44.1% |
| Return on invested capital | – | −21.7% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Net debt / EBITDA | −0.54 | – |
| Interest coverage | 26.8× | – |
| Current ratio | 4.06 (better) | 3.52 |
| Altman Z-score | – | 1.26 |
| Piotroski F-score | – | 5 |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | 8.6% | 53.2% |
| Held by insiders | 45.3% | – |
| Insider net buying, 12 months | −$1.7M | −$988K (better) |
| Short interest, % of float | 0.53% | – |
Go deeper
- KMDA stock overview
- KMDA income statement
- KMDA valuation and score
- ORGO stock overview
- ORGO income statement
- ORGO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.